BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22920222)

  • 1. Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load.
    Gregson JN; Kuri-Cervantes L; Mela CM; Gazzard BG; Bower M; Goodier MR
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):84-8. PubMed ID: 22920222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection.
    Hong HS; Eberhard JM; Keudel P; Bollmann BA; Ahmad F; Ballmaier M; Bhatnagar N; Zielinska-Skowronek M; Schmidt RE; Meyer-Olson D
    AIDS; 2010 Jul; 24(12):1823-34. PubMed ID: 20543659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
    Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
    Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
    Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
    Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
    J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency.
    Farnault L; Chambost H; Michel G; Thuret I; de Saint Basile G; Fischer A; Picard C; Picard C; Orlanducci F; Farnarier C; Moretta A; Olive D
    J Allergy Clin Immunol; 2013 Apr; 131(4):1230-3, 1233.e1-2. PubMed ID: 23069490
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
    Rutjens E; Mazza S; Biassoni R; Koopman G; Ugolotti E; Fogli M; Dubbes R; Costa P; Mingari MC; Greenwood EJ; Moretta L; De Maria A; Heeney JL
    Eur J Immunol; 2010 May; 40(5):1440-50. PubMed ID: 20306468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.
    Mestre G; Garcia F; Martinez E; Milinkovic A; Lopez A; León A; Mora B; Argelich R; Lozano JM; Peña J; Gatell JM; Plana M
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1485-95. PubMed ID: 19025397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China.
    Fu GF; Hao S; Zhao JL; Xu XQ; Guo HX; Hu HY; Yang HT; Li L; Xu JS; Qiu T; Huan XP; Hou YY
    Viral Immunol; 2009 Apr; 22(2):105-16. PubMed ID: 19326997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
    Noyola DE; Fortuny C; Muntasell A; Noguera-Julian A; Muñoz-Almagro C; Alarcón A; Juncosa T; Moraru M; Vilches C; López-Botet M
    Eur J Immunol; 2012 Dec; 42(12):3256-66. PubMed ID: 22965785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.